Related Experiment Video
Updated: Sep 21, 2026

Analytical Techniques for Assaying Nitric Oxide Bioactivity
Published on: June 18, 2012
BASAL RELEASE OF 6-CYANODOPAMINE AND 6-NITRODOPAMINE FROM RAT ISOLATED AORTA AND THEIR ROLE IN VASCULAR RELAXATION
Antônio Tiago Lima1, George Said1, José Britto-Júnior2
1Faculty of Medical Sciences, Department of Pharmacology, University of Campinas (UNICAMP), Campinas, Brazil.
Abstract:
6-Cyanodopamine (6-CYD) and 6-nitrodopamine (6-ND) are newly described endogenous catecholamines. However, their presence and vascular actions in rat aorta remain unclear. Thoracic aortas from male Wistar rats were analyzed for basal catecholamine release by LC-MS/MS. Vascular reactivity was assessed in U-46619-precontracted rings with intact or removed endothelium and after pharmacological inhibition with Nω-nitro-L-arginine methyl ester (L-NAME), 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), indomethacin, SQ-22536, SCH-23390, and haloperidol. Tyrosine hydroxylase (TH) expression was examined by immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). Rat aorta basally released both 6-CYD and 6-ND, with 6-ND levels exceeding 6-CYD. Both catecholamines produced concentration-dependent relaxation, with 6-ND showing greater potency than 6-CYD (pEC50: 8.9±0.5 and 8.5±0.6, respectively). Endothelium removal abolished 6-CYD relaxation and significantly reduced 6-ND relaxation. L-NAME, ODQ, indomethacin, and SQ-22536 significantly inhibited responses to 6-CYD, but not to 6-ND, indicating different mechanisms of action. SQ-22536 also attenuated forskolin- and iloprost-induced relaxation, supporting involvement of adenylyl cyclase/cAMP signaling in 6-CYD responses. SCH-23390 had no effect on 6-CYD- and 6-ND-induced relaxation. Haloperidol reduced the effect of sumanirole- and 6-CYD-induced relaxation but had no effect on 6-ND-induced relaxation, suggesting involvement of D2-like receptor in 6-CYD signaling. Tyrosine hydroxylase protein and mRNA were detected by immunohistochemistry and fluorescent in situ hybridization respectively, in endothelial cells and adventitial neural structures. Rat thoracic aorta basally releases 6-CYD and 6-ND, and although both act as potent vasodilators, they have distinct mechanisms of action. These findings shed new light on mechanisms by which the vascular endothelium regulates vascular tone.
More Related Videos
09:47Measurement of Endothelium-Dependent Vasorelaxation in the Mouse Thoracic Aorta Using Tensometric Small Volume Chamber Myography
Published on: August 12, 2022
08:41Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
Related Concept Videos
Antihypertensive Drugs: Vasodilators
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Drugs Affecting Neurotransmitter Release or Uptake
Autoregulation of Blood Flow
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.